In the latest trading session, 0.67 million Jaguar Health Inc (NASDAQ:JAGX) shares changed hands as the company’s beta touched 0.88. With the company’s most recent per share price at $0.33 changed hands at -$0.14 or -29.42% at last look, the market valuation stands at $5.43M. JAGX’s current price is a discount, trading about -6445.45% off its 52-week high of $21.60. The share price had its 52-week low at $0.42, which suggests the last value was -27.27% down since then. When we look at Jaguar Health Inc’s average trading volume, we note the 10-day average is 0.27 million shares, with the 3-month average coming to 409.93K.
Analysts gave the Jaguar Health Inc (JAGX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended JAGX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Jaguar Health Inc’s EPS for the current quarter is expected to be -0.74.
Jaguar Health Inc (NASDAQ:JAGX) trade information
Instantly JAGX was in red as seen in intraday trades today. With action -30.54%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -67.23%, with the 5-day performance at -30.54% in the red. However, in the 30-day time frame, Jaguar Health Inc (NASDAQ:JAGX) is -63.22% down. Looking at the short shares, we see there were 0.95 million shares sold at short interest cover period of 2.57 days.
Jaguar Health Inc (JAGX) estimates and forecasts
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 3.13M. 1 analysts are of the opinion that Jaguar Health Inc’s revenue for the current quarter will be 3.29M. The estimates for the next quarter sales put growth at 39.94%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 86.10%. The 2025 estimates are for Jaguar Health Inc earnings to increase by 99.26%, but the outlook for the next 5-year period is at 79.17% per year.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.81% of Jaguar Health Inc shares while 1.71% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.01%.
Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. With 59.5 shares estimated at $19368.0 under it, the former controlled 0.36% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.31% of the shares, roughly 50.91 shares worth around $16569.0.
